Φορτώνει......

Nickel pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via both Bcr/Abl-dependent and Bcr/Abl-independent mechanisms

BACKGROUND: Acquired imatinib (IM) resistance is frequently characterized by Bcr-Abl mutations that affect IM binding and kinase inhibition in patients with chronic myelogenous leukemia (CML). Bcr-Abl-T315I mutation is the predominant mechanism of the acquired resistance to IM. Therefore, it is urge...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:	J Hematol Oncol
Κύριοι συγγραφείς:	Lan, Xiaoying, Zhao, Chong, Chen, Xin, Zhang, Peiquan, Zang, Dan, Wu, Jinjie, Chen, Jinghong, Long, Huidan, Yang, Li, Huang, Hongbiao, Carter, Bing Z., Wang, Xuejun, Shi, Xianping, Liu, Jinbao
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	BioMed Central 2016
Θέματα:	Research
Διαθέσιμο Online:	https://ncbi.nlm.nih.gov/pmc/articles/PMC5123219/ https://ncbi.nlm.nih.gov/pubmed/27884201 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-016-0359-x
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Nickel pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via both Bcr/Abl-dependent and Bcr/Abl-independent mechanisms

Παρόμοια τεκμήρια